Freedom Investing Report
  • Sports
  • Politics
  • Stocks
  • Business
  • Sports
  • Politics
  • Stocks
  • Business

Freedom Investing Report

Sports

MLB hits outfielder with 80-game suspension for steroids

by January 9, 2026
January 9, 2026
MLB hits outfielder with 80-game suspension for steroids

Max Kepler, the veteran major league outfielder who most recently played for the Philadelphia Phillies, was suspended 80 games by Major League Baseball on Jan. 9 after testing positive for epitrenbolone, an anabolic steroid.

Kepler, 32, is a free agent and his suspension would begin upon signing with a major league team. He hit 17 home runs in his one season with the Phillies, batting .216 with a .691 OPS. He spent nine previous seasons with the Minnesota Twins, hitting a career-high 36 home runs in 2019. Kepler’s more recent high-water mark was 24 home runs in 2023.

Kepler went 1-for-12 with three walks in the Phillies’ four-game defeat to the Los Angeles Dodgers in the National League Division Series.

Epitrenbolone, according to the United States Anti-Doping Agency, is a metabolite of trenbolone, which is an anabolic steroid intended to increase muscle and appetite in cattle.

This post appeared first on USA TODAY
previous post
San Diego FC moving on from Mexico star Hirving Lozano
next post
MLB Cy Young winner on track for exit with historic contract demand?

Related Posts

Jason Kidd ejected after exchange with official Scott...

January 11, 2026

US sending speedskating team to Olympics with lots...

January 6, 2026

U Turn! Miami returns to national elite after...

January 9, 2026

Why rematch history in CFP favors Oregon vs....

January 9, 2026

Nebraska football lands UNLV transfer Anthony Colandrea as...

January 7, 2026

Puka Nacua stats: Rams star shines in playoff...

January 11, 2026

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1)
    • Sports (237)
    • About Us
    • Contacts
    • Terms & Conditions
    • Privacy Policy
    • Email Whitelisting

    Disclaimer: FreedomInvestingReport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2023 FreedomInvestingReport.com | All Rights Reserved